Global Cell Viability Assays Market Research Report 2022

SKU ID : QYR-21205680 | Publishing Date : 05-Jul-2022 | No. of pages : 90

Detailed TOC of Global Cell Viability Assays Market Research Report 2022

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Cell Viability Assays Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Human Cells
        1.2.3 Microbial Cells
        1.2.4 Animal Cells
    1.3 Market by Application
        1.3.1 Global Cell Viability Assays Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Pharmaceutical and Biotechnology Companies
        1.3.3 Academic and Research Institutes
        1.3.4 Hospital and Diagnostic Laboratories
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Cell Viability Assays Market Perspective (2017-2028)
    2.2 Cell Viability Assays Growth Trends by Region
        2.2.1 Cell Viability Assays Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Cell Viability Assays Historic Market Size by Region (2017-2022)
        2.2.3 Cell Viability Assays Forecasted Market Size by Region (2023-2028)
    2.3 Cell Viability Assays Market Dynamics
        2.3.1 Cell Viability Assays Industry Trends
        2.3.2 Cell Viability Assays Market Drivers
        2.3.3 Cell Viability Assays Market Challenges
        2.3.4 Cell Viability Assays Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Cell Viability Assays Players by Revenue
        3.1.1 Global Top Cell Viability Assays Players by Revenue (2017-2022)
        3.1.2 Global Cell Viability Assays Revenue Market Share by Players (2017-2022)
    3.2 Global Cell Viability Assays Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Cell Viability Assays Revenue
    3.4 Global Cell Viability Assays Market Concentration Ratio
        3.4.1 Global Cell Viability Assays Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Cell Viability Assays Revenue in 2021
    3.5 Cell Viability Assays Key Players Head office and Area Served
    3.6 Key Players Cell Viability Assays Product Solution and Service
    3.7 Date of Enter into Cell Viability Assays Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Cell Viability Assays Breakdown Data by Type
    4.1 Global Cell Viability Assays Historic Market Size by Type (2017-2022)
    4.2 Global Cell Viability Assays Forecasted Market Size by Type (2023-2028)
5 Cell Viability Assays Breakdown Data by Application
    5.1 Global Cell Viability Assays Historic Market Size by Application (2017-2022)
    5.2 Global Cell Viability Assays Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Cell Viability Assays Market Size (2017-2028)
    6.2 North America Cell Viability Assays Market Size by Country (2017-2022)
    6.3 North America Cell Viability Assays Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Cell Viability Assays Market Size (2017-2028)
    7.2 Europe Cell Viability Assays Market Size by Country (2017-2022)
    7.3 Europe Cell Viability Assays Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Cell Viability Assays Market Size (2017-2028)
    8.2 Asia-Pacific Cell Viability Assays Market Size by Country (2017-2022)
    8.3 Asia-Pacific Cell Viability Assays Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Cell Viability Assays Market Size (2017-2028)
    9.2 Latin America Cell Viability Assays Market Size by Country (2017-2022)
    9.3 Latin America Cell Viability Assays Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Cell Viability Assays Market Size (2017-2028)
    10.2 Middle East & Africa Cell Viability Assays Market Size by Country (2017-2022)
    10.3 Middle East & Africa Cell Viability Assays Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Thermo Fisher Scientific
        11.1.1 Thermo Fisher Scientific Company Detail
        11.1.2 Thermo Fisher Scientific Business Overview
        11.1.3 Thermo Fisher Scientific Cell Viability Assays Introduction
        11.1.4 Thermo Fisher Scientific Revenue in Cell Viability Assays Business (2017-2022)
        11.1.5 Thermo Fisher Scientific Recent Development
    11.2 Merck
        11.2.1 Merck Company Detail
        11.2.2 Merck Business Overview
        11.2.3 Merck Cell Viability Assays Introduction
        11.2.4 Merck Revenue in Cell Viability Assays Business (2017-2022)
        11.2.5 Merck Recent Development
    11.3 Bio-Rad
        11.3.1 Bio-Rad Company Detail
        11.3.2 Bio-Rad Business Overview
        11.3.3 Bio-Rad Cell Viability Assays Introduction
        11.3.4 Bio-Rad Revenue in Cell Viability Assays Business (2017-2022)
        11.3.5 Bio-Rad Recent Development
    11.4 GE
        11.4.1 GE Company Detail
        11.4.2 GE Business Overview
        11.4.3 GE Cell Viability Assays Introduction
        11.4.4 GE Revenue in Cell Viability Assays Business (2017-2022)
        11.4.5 GE Recent Development
    11.5 Danaher
        11.5.1 Danaher Company Detail
        11.5.2 Danaher Business Overview
        11.5.3 Danaher Cell Viability Assays Introduction
        11.5.4 Danaher Revenue in Cell Viability Assays Business (2017-2022)
        11.5.5 Danaher Recent Development
    11.6 BD
        11.6.1 BD Company Detail
        11.6.2 BD Business Overview
        11.6.3 BD Cell Viability Assays Introduction
        11.6.4 BD Revenue in Cell Viability Assays Business (2017-2022)
        11.6.5 BD Recent Development
    11.7 PerkinElmer
        11.7.1 PerkinElmer Company Detail
        11.7.2 PerkinElmer Business Overview
        11.7.3 PerkinElmer Cell Viability Assays Introduction
        11.7.4 PerkinElmer Revenue in Cell Viability Assays Business (2017-2022)
        11.7.5 PerkinElmer Recent Development
    11.8 Promega
        11.8.1 Promega Company Detail
        11.8.2 Promega Business Overview
        11.8.3 Promega Cell Viability Assays Introduction
        11.8.4 Promega Revenue in Cell Viability Assays Business (2017-2022)
        11.8.5 Promega Recent Development
    11.9 Biotium
        11.9.1 Biotium Company Detail
        11.9.2 Biotium Business Overview
        11.9.3 Biotium Cell Viability Assays Introduction
        11.9.4 Biotium Revenue in Cell Viability Assays Business (2017-2022)
        11.9.5 Biotium Recent Development
    11.10 Abcam
        11.10.1 Abcam Company Detail
        11.10.2 Abcam Business Overview
        11.10.3 Abcam Cell Viability Assays Introduction
        11.10.4 Abcam Revenue in Cell Viability Assays Business (2017-2022)
        11.10.5 Abcam Recent Development
    11.11 Creative Bioarray
        11.11.1 Creative Bioarray Company Detail
        11.11.2 Creative Bioarray Business Overview
        11.11.3 Creative Bioarray Cell Viability Assays Introduction
        11.11.4 Creative Bioarray Revenue in Cell Viability Assays Business (2017-2022)
        11.11.5 Creative Bioarray Recent Development
    11.12 Biotek Instruments
        11.12.1 Biotek Instruments Company Detail
        11.12.2 Biotek Instruments Business Overview
        11.12.3 Biotek Instruments Cell Viability Assays Introduction
        11.12.4 Biotek Instruments Revenue in Cell Viability Assays Business (2017-2022)
        11.12.5 Biotek Instruments Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Figures, Tables and Charts Available in Global Cell Viability Assays Market Research Report 2022

List of Tables
    Table 1. Global Cell Viability Assays Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Human Cells
    Table 3. Key Players of Microbial Cells
    Table 4. Key Players of Animal Cells
    Table 5. Global Cell Viability Assays Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Cell Viability Assays Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Cell Viability Assays Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Cell Viability Assays Market Share by Region (2017-2022)
    Table 9. Global Cell Viability Assays Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Cell Viability Assays Market Share by Region (2023-2028)
    Table 11. Cell Viability Assays Market Trends
    Table 12. Cell Viability Assays Market Drivers
    Table 13. Cell Viability Assays Market Challenges
    Table 14. Cell Viability Assays Market Restraints
    Table 15. Global Cell Viability Assays Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Cell Viability Assays Market Share by Players (2017-2022)
    Table 17. Global Top Cell Viability Assays Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Viability Assays as of 2021)
    Table 18. Ranking of Global Top Cell Viability Assays Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Cell Viability Assays Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Cell Viability Assays Product Solution and Service
    Table 22. Date of Enter into Cell Viability Assays Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Cell Viability Assays Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Cell Viability Assays Revenue Market Share by Type (2017-2022)
    Table 26. Global Cell Viability Assays Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Cell Viability Assays Revenue Market Share by Type (2023-2028)
    Table 28. Global Cell Viability Assays Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Cell Viability Assays Revenue Market Share by Application (2017-2022)
    Table 30. Global Cell Viability Assays Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Cell Viability Assays Revenue Market Share by Application (2023-2028)
    Table 32. North America Cell Viability Assays Market Size by Country (2017-2022) & (US$ Million)
    Table 33. North America Cell Viability Assays Market Size by Country (2023-2028) & (US$ Million)
    Table 34. Europe Cell Viability Assays Market Size by Country (2017-2022) & (US$ Million)
    Table 35. Europe Cell Viability Assays Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Asia-Pacific Cell Viability Assays Market Size by Region (2017-2022) & (US$ Million)
    Table 37. Asia-Pacific Cell Viability Assays Market Size by Region (2023-2028) & (US$ Million)
    Table 38. Latin America Cell Viability Assays Market Size by Country (2017-2022) & (US$ Million)
    Table 39. Latin America Cell Viability Assays Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Middle East & Africa Cell Viability Assays Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Middle East & Africa Cell Viability Assays Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Thermo Fisher Scientific Company Detail
    Table 43. Thermo Fisher Scientific Business Overview
    Table 44. Thermo Fisher Scientific Cell Viability Assays Product
    Table 45. Thermo Fisher Scientific Revenue in Cell Viability Assays Business (2017-2022) & (US$ Million)
    Table 46. Thermo Fisher Scientific Recent Development
    Table 47. Merck Company Detail
    Table 48. Merck Business Overview
    Table 49. Merck Cell Viability Assays Product
    Table 50. Merck Revenue in Cell Viability Assays Business (2017-2022) & (US$ Million)
    Table 51. Merck Recent Development
    Table 52. Bio-Rad Company Detail
    Table 53. Bio-Rad Business Overview
    Table 54. Bio-Rad Cell Viability Assays Product
    Table 55. Bio-Rad Revenue in Cell Viability Assays Business (2017-2022) & (US$ Million)
    Table 56. Bio-Rad Recent Development
    Table 57. GE Company Detail
    Table 58. GE Business Overview
    Table 59. GE Cell Viability Assays Product
    Table 60. GE Revenue in Cell Viability Assays Business (2017-2022) & (US$ Million)
    Table 61. GE Recent Development
    Table 62. Danaher Company Detail
    Table 63. Danaher Business Overview
    Table 64. Danaher Cell Viability Assays Product
    Table 65. Danaher Revenue in Cell Viability Assays Business (2017-2022) & (US$ Million)
    Table 66. Danaher Recent Development
    Table 67. BD Company Detail
    Table 68. BD Business Overview
    Table 69. BD Cell Viability Assays Product
    Table 70. BD Revenue in Cell Viability Assays Business (2017-2022) & (US$ Million)
    Table 71. BD Recent Development
    Table 72. PerkinElmer Company Detail
    Table 73. PerkinElmer Business Overview
    Table 74. PerkinElmer Cell Viability Assays Product
    Table 75. PerkinElmer Revenue in Cell Viability Assays Business (2017-2022) & (US$ Million)
    Table 76. PerkinElmer Recent Development
    Table 77. Promega Company Detail
    Table 78. Promega Business Overview
    Table 79. Promega Cell Viability Assays Product
    Table 80. Promega Revenue in Cell Viability Assays Business (2017-2022) & (US$ Million)
    Table 81. Promega Recent Development
    Table 82. Biotium Company Detail
    Table 83. Biotium Business Overview
    Table 84. Biotium Cell Viability Assays Product
    Table 85. Biotium Revenue in Cell Viability Assays Business (2017-2022) & (US$ Million)
    Table 86. Biotium Recent Development
    Table 87. Abcam Company Detail
    Table 88. Abcam Business Overview
    Table 89. Abcam Cell Viability Assays Product
    Table 90. Abcam Revenue in Cell Viability Assays Business (2017-2022) & (US$ Million)
    Table 91. Abcam Recent Development
    Table 92. Creative Bioarray Company Detail
    Table 93. Creative Bioarray Business Overview
    Table 94. Creative Bioarray Cell Viability AssaysProduct
    Table 95. Creative Bioarray Revenue in Cell Viability Assays Business (2017-2022) & (US$ Million)
    Table 96. Creative Bioarray Recent Development
    Table 97. Biotek Instruments Company Detail
    Table 98. Biotek Instruments Business Overview
    Table 99. Biotek Instruments Cell Viability AssaysProduct
    Table 100. Biotek Instruments Revenue in Cell Viability Assays Business (2017-2022) & (US$ Million)
    Table 101. Biotek Instruments Recent Development
    Table 102. Research Programs/Design for This Report
    Table 103. Key Data Information from Secondary Sources
    Table 104. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Cell Viability Assays Market Share by Type: 2021 VS 2028
    Figure 2. Human Cells Features
    Figure 3. Microbial Cells Features
    Figure 4. Animal Cells Features
    Figure 5. Global Cell Viability Assays Market Share by Application in 2021 & 2028
    Figure 6. Pharmaceutical and Biotechnology Companies Case Studies
    Figure 7. Academic and Research Institutes Case Studies
    Figure 8. Hospital and Diagnostic Laboratories Case Studies
    Figure 9. Others Case Studies
    Figure 10. Cell Viability Assays Report Years Considered
    Figure 11. Global Cell Viability Assays Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Cell Viability Assays Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Cell Viability Assays Market Share by Region: 2021 VS 2028
    Figure 14. Global Cell Viability Assays Market Share by Players in 2021
    Figure 15. Global Top Cell Viability Assays Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Viability Assays as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Cell Viability Assays Revenue in 2021
    Figure 17. North America Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. North America Cell Viability Assays Market Share by Country (2017-2028)
    Figure 19. United States Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Cell Viability Assays Market Share by Country (2017-2028)
    Figure 23. Germany Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. France Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. U.K. Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Italy Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Russia Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Nordic Countries Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Cell Viability Assays Market Share by Region (2017-2028)
    Figure 31. China Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Japan Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. South Korea Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Southeast Asia Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. India Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Australia Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Cell Viability Assays Market Share by Country (2017-2028)
    Figure 39. Mexico Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Brazil Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Cell Viability Assays Market Share by Country (2017-2028)
    Figure 43. Turkey Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Saudi Arabia Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Thermo Fisher Scientific Revenue Growth Rate in Cell Viability Assays Business (2017-2022)
    Figure 46. Merck Revenue Growth Rate in Cell Viability Assays Business (2017-2022)
    Figure 47. Bio-Rad Revenue Growth Rate in Cell Viability Assays Business (2017-2022)
    Figure 48. GE Revenue Growth Rate in Cell Viability Assays Business (2017-2022)
    Figure 49. Danaher Revenue Growth Rate in Cell Viability Assays Business (2017-2022)
    Figure 50. BD Revenue Growth Rate in Cell Viability Assays Business (2017-2022)
    Figure 51. PerkinElmer Revenue Growth Rate in Cell Viability Assays Business (2017-2022)
    Figure 52. Promega Revenue Growth Rate in Cell Viability Assays Business (2017-2022)
    Figure 53. Biotium Revenue Growth Rate in Cell Viability Assays Business (2017-2022)
    Figure 54. Abcam Revenue Growth Rate in Cell Viability Assays Business (2017-2022)
    Figure 55. Creative Bioarray Revenue Growth Rate in Cell Viability Assays Business (2017-2022)
    Figure 56. Biotek Instruments Revenue Growth Rate in Cell Viability Assays Business (2017-2022)
    Figure 57. Bottom-up and Top-down Approaches for This Report
    Figure 58. Data Triangulation
    Figure 59. Key Executives Interviewed